Correction: BMC Psychiatry (2025) 25:1113
10.1186/s12888-025-07625-2
Following the publication of the original article [1], the authors identified errors in the adverse reaction scale scoring in Supplementary file 1, as well as in two sentences within the article. The table below outlines the corrections that have been implemented in the original article.
| Section | Originally published text | Corrected text |
|---|---|---|
| Abstract | The Naranjo adverse reaction probability scale score of seven suggested a probable association between the prescribed psychotropics and ischaemic priapism. | The Naranjo adverse reaction probability scale score of eight suggested a probable association between the prescribed psychotropics and ischaemic priapism. |
| Case presentation | Naranjo et al. Adverse Reaction Probability Scale [7] score of seven indicated a ‘probable’ association between prescribed psychotropics and the development of ischaemic priapism (Supplementary file 1). | Naranjo et al. Adverse Reaction Probability Scale [7] score of eight indicated a ‘probable’ association between prescribed psychotropics and the development of ischaemic priapism (Supplementary file 1). |
The original article [1] has been corrected.
Supplementary Information
Below is the link to the electronic supplementary material.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Haque T, et al. Priapism following antipsychotic-gabapentinoid combination in a case of treatment-resistant schizophrenia: a case report. BMC Psychiatry. 2025;25:1113. 10.1186/s12888-025-07625-2. [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
